Correlation between 99mTc-MIBI uptake and angiogenesis in MIBI-positive breast lesions

Nuclear Medicine and Biology

Volumn 32, Issue 5, 2005, Pages 465-472

  Bekiş, Recep ^a   Degirmenci, Berna ^a   Aydin, Aysel ^a   Ozdogan, Ozhan ^a   Canda, Tulay ^a   Durak, Hatice ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

99mTc MIBI; Angiogenesis; Breast

Indexed keywords

ANTIGEN; AVIDIN; BIOTIN; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MONOCLONAL ANTIBODY; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ANGIOGENESIS; ARTICLE; BIOTINYLATION; BREAST CANCER; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG UPTAKE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; PATHOLOGY; SCINTIMAMMOGRAPHY; STANDARD; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VASCULAR ENDOTHELIUM; AGED; BREAST TUMOR; FEMALE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); SCINTISCANNING; VASCULARIZATION;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI;

EID: 20744449984     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2005.04.008     Document Type: Article

References (25)

1. I. Khalkhali, I. Mena, and L. Diggles Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using Tc-99m-Sestamibi Eur J Nucl Med 21 4 1994 357 362
2. H. Palmedo, F. Grunwald, H. Bender, A. Schomburg, P. Mallmann, and D. Krebs Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging Eur J Nucl Med 23 8 1996 940 946
3. E. Bombardieri, F. Crippa, L. Maffioli, and M. Greco Nuclear medicine techniques for the study of breast cancer Eur J Nucl Med 24 7 1997 809 824
4. R. Taillefer The role of Tc-99m sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis Semin Nucl Med 29 1 1999 16 40
5. W.S. Omar, S. Eissa, H. Moustafa, H. Farag, I. Ezzat, and H.M. Abdel-Dayem Role of thallium-201 chloride and Tc-99m methoxy-isobutyl-isonitrite (sestaMIBI) in evaluation of breast masses: correlation with the immunohistochemical characteristic parameters (Ki-67, PCNA, Bcl, and angiogenesis) in malignant lesions Anticancer Res 17 3B 1997 1639 1644
6. R.D. Okada, D. Glover, T. Gaffney, and S. Williams Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile Circulation 77 2 1988 491 498
7. J.R. Ballinger, H.A. Hua, B.W. Berry, P. Firby, and I. Boxen 99Tcm-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant Nucl Med Commun 16 4 1995 253 257
8. S. Del Vecchio, A. Ciarmiello, L. Pace, M.I. Potena, M.V. Carriero, and C. Mainolfi Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients J Nucl Med 38 9 1997 1348 1351
9. F. Scopinaro, O. Schillaci, M. Scarpini, P.L. Mingazzini, L. Di Macio, and M. Banci Technetium-99m-sestamibi: an indicator of breast cancer invasiveness Eur J Nucl Med 21 9 1994 984 987
10. J.H. Yoon, H.S. Bom, H.C. Song, J.H. Lee, and Y.J. Jaegal Double-phase Tc-99m sestamibi scintimammography to assess angiogenesis and P-glycoprotein expression in patients with untreated breast cancer Clin Nucl Med 24 5 1999 314 318
11. H. Ohira, K. Kubota, N. Ohuchi, Y. Harada, H. Fukuda, and S. Satomi Comparison of intratumoral distribution of 99mTc-MIBI and deoxyglucose in mouse breast cancer models J Nucl Med 41 9 2000 1561 1568
12. J.A. Cutrone, L.S. Yospur, I. Khalkhali, J. Tolmos, A. Devito, and L. Diggles Immunohistologic assessment of technetium-99m-MIBI uptake in benign and malignant breast lesions J Nucl Med 39 3 1998 449 453
13. S.W. Kim, S.S. Park, S.J. Ahn, K.W. Chung, W.K. Moon, and J.G. Im Identification of angiogenesis in primary breast carcinoma according to the image analysis Breast Cancer Res Treat 74 2 2002 121 129
14. D.A. Mankoff, L.K. Dunnwald, J.R. Gralow, G.K. Ellis, E.K. Schubert, and A.W. Charlop [Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flow Nucl Med Biol 29 7 2002 719 727
15. E.R. Weibel Principles and methods for the morphometric study of the lung and other organs Lab Invest 12 1963 131 155
16. J. Folkman Role of angiogenesis in tumor growth and metastasis Semin Oncol 29 6, Suppl 16 2002 15 18
17. N. Weidner, J.P. Semple, W.R. Welch, and J. Folkman Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma N Engl J Med 324 1 1991 1 8
18. K. Axelsson, B.M. Ljung, D.H. Moore II, A.D. Thor, K.L. Chew, and S.M. Edgerton Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma J Natl Cancer Inst 87 13 1995 997 1008
19. E. Ozer, T. Canda, and B. Kurtodlu The role of angiogenesis, laminin and CD44 expression in metastatic behavior of early-stage low-grade invasive breast carcinomas Cancer Lett 121 2 1997 119 123
20. L.A. Habel, and J.L. Stanford Hormone receptors and breast cancer Epidemiol Rev 15 1 1993 209 219
21. J. Folkman What is the evidence that tumours are angiogenesis dependent? J Natl Cancer Inst 82 1 1990 4 6
22. L. Liotta, J. Kleinerman, and G. Saidel Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation Cancer Res 34 5 1974 997 1004
23. N. Weidner, J.P. Semple, W.R. Welch, and J. Folkman Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma N Engl J Med 324 1 1991 1 8
24. G. Gasparini Prognostic value of vascular endothelial growth factor in breast cancer Oncologist 5 Suppl 1 2000 37 44
25. K. Samoto, K. Ikezaki, M. Ono, T. Shono, K. Kohno, and M. Kuwano Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors Cancer Res 55 5 1995 1189 1193